ATLANTA, GA – – (ACCESSWIRE – October 19, 2022) – – Holzer & Holzer, LLC is investigating whether Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA) complied with federal securities laws. On October 19, 2022, Hindenburg Research published a report alleging that many of the key safety studies of Establishment Labs’ breast implants have undisclosed or under-disclosed conflicts of interest and that the lead surgeon on an unconflicted paper “received pushback from Establishment Labs for publishing evidence showing complication rates higher than reported by the Company.” Following this report, the Company’s stock price dropped.
If you purchased Establishment Labs stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at email@example.com or Joshua Karr, Esq. at firstname.lastname@example.org, call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/establishment-labs/ to discuss your legal rights.